Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.3864 per EA under NDC 13107006099. Its NADAC has been published 629 times since Jun 11, 2014.
Strength
300; 60 mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107006099
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA202800On Market Since
4/15/2013
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 629 times since Jun 11, 2014, and over the history we have for it it has risen 103.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3864 per EA |
|---|---|
| All-time high | $0.4850 (Jul 10, 2024) |
| All-time low | $0.1794 (Sep 17, 2014) |
| 52-week high | $0.4473 |
| 52-week low | $0.3855 |
| Median price | $0.2290 |
| Average price | $0.2855 |
| Largest weekly change | +70.9% (Nov 18, 2015) |
| Weeks tracked | 629 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Aurolife Pharma LLC, is $0.3864 per EA (NDC 13107006099), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has risen 103.8%. It has been tracked across 629 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Jun 11, 2014, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.1794 (Sep 17, 2014) to a high of $0.4850 (Jul 10, 2024), with a median of $0.2290 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ACETAMINOPHEN-COD #4 TABLET, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 13107006099) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification